Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Sapanisertib
Malignant Leptomeningeal Tumor
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Metastatic Malignant Neoplasm In The Brain
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Ovarian Clear Cell Cystadenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Ovarian Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Ovarian Mucinous Cystadenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Ovarian Serous Cystadenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Cancer Or Benign Tumor
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Fallopian Tube Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Ovarian Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Sargramostim
Pancreatic Acinar Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Sargramostim
Pancreatic Ductal Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Sodium Thiosulfate
Digestive System Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Tacrolimus
Cutaneous Melanoma
National Cancer Institute (NCI)
P1
CC
(43)
Tacrolimus
Cutaneous Neuroendocrine Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Tacrolimus
Skin Basal Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Tacrolimus
Metastatic Melanoma
National Cancer Institute (NCI)
P1
CC
(43)
Tacrolimus
Skin Squamous Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Tacrolimus
Melanoma
National Cancer Institute (NCI)
P1
CC
(43)
Tak-243
Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Tak-243
Indolent B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Tak-243
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Tak-243
Myelodysplastic Syndrome With Excess Blasts
National Cancer Institute (NCI)
P1
CC
(43)
Tak-243
Acute Myeloid Leukemia
National Cancer Institute (NCI)
P1
CC
(43)
Showing 2976 to 3000 of 3,272 assets
Previous
Page 120 of 131
Next